Skip to main content
Medical information Clinical review pending

Genetic Testing

DRD4 Gene Attention Deficit Hyperactivity Disorder Genetic Test

Genetic test analyzing the DRD4 gene to understand potential genetic links to Attention Deficit Hyperactivity Disorder (ADHD).

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube) or Saliva sample (collection kit provided). Confirm with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. Patients can eat and drink normally before sample collection.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the DRD4 Gene Attention Deficit Hyperactivity Disorder Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals exhibiting symptoms consistent with ADHD.
  • ✓Children or adults with a family history of ADHD.
  • ✓Patients where clinical diagnosis is unclear.
  • ✓Assisting in understanding potential genetic contributions to ADHD.
  • ✓Guiding personalized management approaches.
02

In plain language

What this test helps you understand

This test helps identify specific genetic variations in the DRD4 gene associated with ADHD. It can provide additional information to support clinical diagnosis and potentially guide management strategies, especially when ADHD symptoms are complex or family history is significant. It is not a standalone diagnostic test.
The DRD4 Gene Attention Deficit Hyperactivity Disorder (ADHD) NGS Genetic DNA Test is an advanced diagnostic tool used to explore the genetic factors associated with ADHD. ADHD is a neurodevelopmental disorder often characterized by persistent patterns of inattention and/or hyperactivity-impulsivity that interfere with functioning or development. This test analyzes specific variations within the DRD4 gene, which plays a role in dopamine signaling in the brain, potentially influencing behavior and cognitive functions related to ADHD. Understanding these genetic factors can provide valuable insights for diagnosis, management, and personalized care plans. This test is intended to complement clinical evaluation, not replace it.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. Patients can eat and drink normally before sample collection.
SampleBlood sample (EDTA tube) or Saliva sample (collection kit provided). Confirm with the laboratory before booking.
MethodologyNext-Generation Sequencing (NGS) is used to analyze the DRD4 gene for relevant variations.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes only specific variations in the DRD4 gene. ADHD is a complex condition influenced by multiple genes and environmental factors. A negative or inconclusive result does not rule out ADHD. Results should be interpreted by a qualified healthcare professional in conjunction with clinical findings.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The DRD4 gene provides instructions for making a protein called the dopamine receptor D4. This receptor is involved in brain signaling pathways related to mood, attention, and behavior.
No, this test cannot diagnose ADHD on its own. It identifies genetic variations associated with ADHD risk but must be interpreted alongside clinical evaluation by a healthcare professional.
A positive result indicates the presence of specific genetic variations in the DRD4 gene linked to ADHD. It suggests a potential genetic predisposition but does not confirm the diagnosis.
Yes, this test can be performed on children, but the interpretation of results should consider the child's age and developmental stage. Consultation with a paediatrician or genetic counsellor is recommended.
Results are typically provided in a detailed report. A genetic counsellor or healthcare provider can help explain the findings and their implications.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp